All terms in HP
| Label | Id | Description |
|---|---|---|
| Increased circulating antibody level | HP_0010702 | |
| Increased globoside Gb4 level | HP_0410366 | |
| Abnormal glycosphingolipid metabolism | HP_0004343 | |
| Increased disialylated core 1 O-glycan level | HP_0410365 | |
| Increased globoside Gb3 level | HP_0410368 | |
| Increased hepatitis A virus antibody level | HP_0410367 | |
| Decreased O-mannosyl glycans on alpha-dystroglycan | HP_0410362 | |
| Decreased core 1 O-glycan level | HP_0410361 | |
| Abnormal core 1 O-glycan level | HP_0410359 | |
| Decreased monosialylated core 1 O-glycan level | HP_0410364 | |
| Increased monosialylated core 1 O-glycan level | HP_0410363 | |
| Increased core 1 O-glycan level | HP_0410360 | |
| Decreased high-mannose N-glycan level | HP_0410358 | |
| Abnormal high-mannose N-glycan level | HP_0410356 | |
| Decreased sialylated N-glycan level | HP_0410355 | |
| Increased sialylated N-glycan level | HP_0410354 | |
| Increased high-mannose N-glycan level | HP_0410357 | |
| Abnormal complex N-glycan level | HP_0410351 | |
| Increased urinary fucosylated oligosaccharide | HP_0410350 | |
| Decreased complex N-glycan level | HP_0410353 |